TECH Temel İstatistikler
YÜKSEK
72.12
Açık
71.60
Hacim
3.07M
Düşük
71.50
Önceki Kapanış
71.77
İşlem Değeri
221.03M
52H En Yüksek
72.16
Göreceli Hacim
0.367
Dalgalanma (%)
0.86%
52H En Düşük
43.20
Devir Oranı
1.96%
Piyasa Değeri
11.18B
F/K (TTM)
103.59
F/K (Yıllık)
153.447
GD/DD
5.39
F/S
9.28
Hisse Başına Kazanç (EPS)
0.696
Temettü (TTM)
0.317
Temettü Verimi
0.45%
Dolaşımdaki hisseler
156.56M
Para Birimi
USD
TECH Fiyat Performansı
7 gün
30 gün
90 gün
180 gün
Yıl başından bugüne
1 Yıl
TECH Para Akışı Dağılımı
TECH Günlük Açığa Satış Hacmi
TECH Short Interest Geçmişi
TECH Hisse Özeti
As of 2026-07-18, the Bio-Techne Corp (TECH) stock price today is 72.12. Based on this price, the company has a market capitalization of $11.18B, with a P/E ratio of 103.59.
On 2026-07-18, TECH traded between 71.50 and 72.12. Today’s stock price is 0.87% above the daily low and 0.00% below the daily high, placing TECH üst seviyesine yakın its most recent trading range.
Trading volume currently stands at 3.07M, compared with an average daily volume of 8.38M. This suggests that trading activity is olağan seviyesinin belirgin şekilde altında than usual.
Over the past year, Bio-Techne Corp shares have traded between 43.20 and 72.16. At today’s price, TECH is 66.94% above its 52-week low and 0.06% below its 52-week high.
TECH İlgili haberler
Hakkında TECH
Şirket adı
Bio-Techne Corp
Sektör
Health Technology
Endüstri
Biotechnology
Borsalar
Nasdaq
Çalışan Sayısı
3,100
Lot Büyüklüğü
100
Resmî web sitesi
Para Birimi
USD
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Related Stocks
© 2026 CoinGlass, all rights reserved
